Last reviewed · How we verify
NCT05167227: LC&FIRP
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
NA trial testing Extension for Community Healthcare Outcomes in SARS-CoV-2 Acute Respiratory Disease in 20 participants. Participants enrolled and being followed up; not accepting new ones.
20 November 2024
Quick facts
| Lead sponsor | Family Health Centers of San Diego |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 30 November 2021 |
| Primary completion | 20 November 2024 |
| Estimated completion | 28 November 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Extension for Community Healthcare Outcomes
Conditions studied
- SARS-CoV-2 Acute Respiratory Disease — all drugs for SARS-CoV-2 Acute Respiratory Disease →
- Myalgic Encephalomyelitis — all drugs for Myalgic Encephalomyelitis →
- Chronic Fatigue Syndrome — all drugs for Chronic Fatigue Syndrome →
- Post-acute Sequelae of SARS-COV-2 Infection — all drugs for Post-acute Sequelae of SARS-COV-2 Infection →
Sponsor
Family Health Centers of San Diego
Who can join
18 and older, any sex, with SARS-CoV-2 Acute Respiratory Disease or Myalgic Encephalomyelitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of the present research is to determine the effectiveness of Family Health Center of San Diego's Long COVID and Fatiguing Illness Recovery Program (LC\&FIRP) on clinician- and patient-level outcomes. LC\&FIRP is comprised of a teleECHO program focused on multi-specialty case-consultation and peer-to-peer sharing of emerging best practices to support management of complex cases associated with Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and other post-infectious fatiguing illnesses (PIFI). Our secondary objective is to determine the feasibility, acceptability, and sustainability of LC\&FIRP. Our findings should provide a fuller understanding of the potential impact of innovative technology enabled multi-disciplinary team-based care models in low-resource, community-based primary care settings.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A technology-enabled multi-disciplinary team-based care model for the management of Long COVID and other fatiguing illnesses within a federally qualified health center: protocol for a two-arm, single-blind, pragmatic, quality improvement professional cluster randomized controlled
Godino JG, Samaniego JC, Sharp SP, Taren D, et al · · 2023 · cited 5× · PMID 37573421 · DOI 10.1186/s13063-023-07550-3
Verify or expand the search:
- PubMed search for NCT05167227
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Family Health Centers of San Diego trials
Trials by the same sponsor.
- NCT05750537 — Enhanced Multicomponent Proactive Navigator-Assisted Cessation of Tobacco Use in Low-Income Patients · NA · unknown
- NCT04741750 — Increasing HCV Linkage to Care Among People Who Inject Drugs · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05167227 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Family Health Centers of San Diego
- Last refreshed: 6 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05167227.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing